brokerbase

About tradingpattern.net

The movement of a security's price over a specific time period.

dedicated to value creation and applying the scientific method in finance

Search


www.brokerbase.ch network - market statistics - weekly update

www.brokerbase.ch High dividend yield stocks

www.brokerbase.ch network

3M Activision Blizzard Adobe Systems Affimetrix Airlines Akamai Tech Alcoa Altera Amazon.com American Express American Tower Amgen Amylin Pharma Analyst Rating AngloGold Apollo Group Apple Applied Materials AT&T Autodesk Automatic Data Processing Baidu Bank of America Baxter Bed Bath & Beyond Blackrock Boeing Broadcom C.H. Robinson CA Caterpillar Celgene Cephalon Charts Check Point Software Chevron Cintas Corporation Cisco Systems Citigroup Citrix Coca Cola Cognizant Comcast Costco Wholesale Cree Dell DENTSPLY DIRECTV Discount, Variety Stores DISH Disney Dow 30 Downgrade Dr. Reddy's Laboratories Du Pont eBay Electronic Arts EMC Corporation Expedia Express Scripts Extreme Networks Exxon Mobil FANNIE MAE Fastenal First Solar Fiserv Flextronics FLIR Ford Foster Wheeler FREDDIE MAC Freeport-McMoRan Garmin Genentech General Electric Genzyme Gilead Sciences Golden Star Resources Goldman Sachs Google Hansen Natural Hardware Healthcare Hecla Mining Henry Schein Hewlett Packard Hologic Home Depot Human Genome Science IBM Illumina Industry Infosys Initial Recommendation Intel InterActive Corp Intuit Intuitive Surgical Johnson & Johnson Joy Global JP Morgan Juniper Networks KKR KLA-Tencor Kraft Foods Lam Research Level 3 Liberty Global Liberty Media Life Technologies Linear Technology Lockheed Martin Logitech Marvell Technology MasterCard Maxim Integrated McDonalds Merck Merril Lynch Microchip Technology Microsoft Millicom Morgan Stanley Nasdaq 100 NetApp NETFLIX Network Network Appliance Newmont Mining News Corporation NII Holdings Noble NVIDIA O'Reilly Automotive Occidental Petroleum Oracle PACCAR Patterson Paychex Petrohawk PETROLEO BRASILEIRO Pfizer Procter & Gamble Qualcomm Quanta Renhe Commercial Holdings Research in Motion Riverbed Technology Ross Stores Royal Gold Ryanair S&P 500 salesforce.com SanDisk Seagate Sears Holdings Semiconductor - Integrated Circuits Services Sigma-Aldrich Software Southwest Airlines Staples Starbucks Steel & Iron Steel Dynamics Stericycle Symantec Synaptics Technology Teva Texas Instruments Ticker Travelers Uncategorized United Continental Holdings United Technologies Upgrade Urban Outfitters VeriSign Verizon Vertex Pharmaceuticals Visa Wal Mart Warner Chilcott Wells Fargo Wynn Resorts Xilinx XTO Yahoo Zoltek

www.brokerbase.ch network - archived market statistics

Blogroll

Recent Posts

Merck

« Previous Entries

Merck halten – New Analyst Rating from National-Bank AG

Tuesday, May 15th, 2012

Merck halten – New Analyst Rating from National-Bank AG

Tuesday, May 15th, 2012

Merck KGaA will bei Serono kraeftig sparen – Neue Mittelfristziele

Tuesday, May 15th, 2012

Merck KGaA startet schwach ins Jahr

Tuesday, May 15th, 2012

Merck hold – New Analyst Rating from Societe Generale Group S.A.

Thursday, May 10th, 2012

Merck KGaA – Studienergebnisse mit Erbitux zeigten keinen Erfolg

Wednesday, May 9th, 2012

Merck & Co behaelt Patentschutz fuer wichtige Umsatztraeger

Sunday, April 29th, 2012

Merck & Co steigert Gewinn zum Jahresauftakt deutlich

Friday, April 27th, 2012

Merck verkaufen – New Analyst Rating from Norddeutsche Landesbank (Nord/LB)

Tuesday, April 24th, 2012

Merck KGaA baut in der Schweiz massiv Stellen ab

Tuesday, April 24th, 2012

Merck outperform – New Analyst Rating from Sanford C. Bernstein and Co., Inc.

Monday, April 23rd, 2012

Merck KGaA stimmt Aktionaere auf "signifikante" Kostensenkung ein

Friday, April 20th, 2012

Merck kauft sich Medikamentenkandidat gegen Krebs ein

Monday, April 16th, 2012

Merck KGaA vereinbart Kooperation mit Kosmetikzulieferer

Monday, April 16th, 2012

Merck neutral – New Analyst Rating from Exane-BNP Paribas SA

Tuesday, April 10th, 2012

Merck neutral – New Analyst Rating from Exane-BNP Paribas SA

Monday, April 9th, 2012

Merck neutral – New Analyst Rating from Exane-BNP Paribas SA

Friday, April 6th, 2012

Merck neutral – New Analyst Rating from Exane-BNP Paribas SA

Thursday, April 5th, 2012

Merck neutral – New Analyst Rating from WestLB AG

Wednesday, April 4th, 2012

Merck neutral – New Analyst Rating from Citigroup Corp.

Thursday, March 29th, 2012

Merck neutral – New Analyst Rating from Citigroup Corp.

Wednesday, March 28th, 2012

Merck outperform – New Analyst Rating from Sanford C. Bernstein and Co., Inc.

Tuesday, March 27th, 2012

Merck equal-weight – New Analyst Rating from Barclays Capital

Friday, March 16th, 2012

Merck equal-weight – New Analyst Rating from Barclays Capital

Thursday, March 15th, 2012

Merck buy – New Analyst Rating from Deutsche Bank AG

Monday, March 12th, 2012

Merck buy – New Analyst Rating from Deutsche Bank AG

Friday, March 9th, 2012

Merck verkaufen – New Analyst Rating from Hamburger Sparkasse AG (Haspa)

Thursday, March 8th, 2012

Merck verkaufen – New Analyst Rating from Hamburger Sparkasse AG (Haspa)

Wednesday, March 7th, 2012

Auch Merck KGaA und Biotest sollen auf griechische Schulden verzichten

Wednesday, March 7th, 2012

Merck halten – New Analyst Rating from Independent Research GmbH

Wednesday, March 7th, 2012

Merck verkaufen – New Analyst Rating from Norddeutsche Landesbank (Nord/LB)

Wednesday, March 7th, 2012

Merck & Co gibt schwachen Ausblick fuer das erste Quartal

Tuesday, March 6th, 2012

Merck halten – New Analyst Rating from National-Bank AG

Tuesday, March 6th, 2012

Merck KGaA schliesst 2012 wegen Einmalkosten Gewinnrueckgang nicht aus

Tuesday, March 6th, 2012

Merck verkaufen – New Analyst Rating from Norddeutsche Landesbank (Nord/LB)

Monday, March 5th, 2012

Merck halten – New Analyst Rating from Independent Research GmbH

Thursday, March 1st, 2012

Merck neutral – New Analyst Rating from UBS AG

Thursday, March 1st, 2012

Merck KGaA will in allen Regionen und Sparten Stellen streichen

Friday, February 24th, 2012

Merck neutral – New Analyst Rating from WestLB AG

Thursday, February 23rd, 2012

Merck neutral – New Analyst Rating from WestLB AG

Wednesday, February 22nd, 2012

Merck KGaA verkauft Batterie-Elektrolyte-Aktivitaeten an BASF

Tuesday, February 21st, 2012

Merck verkaufen – New Analyst Rating from Hamburger Sparkasse AG (Haspa)

Thursday, February 16th, 2012

Merck verkaufen – New Analyst Rating from Hamburger Sparkasse AG (Haspa)

Wednesday, February 15th, 2012

Merck & Co erhaelt in den USA Zulassung fuer Augenmittel Zioptan

Monday, February 13th, 2012

Merck verkaufen – New Analyst Rating from Norddeutsche Landesbank (Nord/LB)

Friday, February 10th, 2012 « Previous Entries